NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.37
-$0.62 (-31.16%)
Nov 2, 2026, 2:54 PM ET · Market open
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.2M | -3.2M | -2.35M | -2.35M | -1.77M | -2.11M | -3.03M | -2.99M | -3.29M | -2.9M | -3.48M | -2.99M | -3.38M | -3.32M | -3.59M | -3.26M | -1.65M | -880K | -951K | -2.11M | -1.12M | -1.12M | -325K | -325K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 2.17M | n/a | -3.72M | 3.69M | n/a | 67K | 206K | 335K | 144K | 572K | n/a | n/a | 11K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.21M | -3.21M | -2.35M | -2.35M | -1.8M | -2.15M | -857K | -5.4M | -2.95M | 784K | -5.23M | -2.92M | -3.15M | -2.99M | -3.48M | -2.72M | -101K | -888K | -928K | -2.12M | -1.1M | -1.1M | -311K | -311K |
Net Income | -3.21M | -3.21M | -2.35M | -2.35M | -1.8M | -2.15M | -857K | -5.4M | -2.95M | 784K | -5.23M | -2.92M | -3.15M | -2.99M | -3.48M | -2.72M | -101K | -888K | -928K | -2.12M | -1.1M | -1.1M | -311K | -311K |
Selling & General & Admin | 1.33M | 1.33M | 1.09M | 1.09M | 685K | 946K | 1.46M | 1.11M | 1.33M | 1.27M | 1.57M | 1.14M | 1.84M | 1.61M | 1.72M | 1.97M | 1.6M | 361K | 453K | 92K | 138.5K | 138.5K | 58K | 58K |
Research & Development | 1.86M | 1.86M | 1.25M | 1.25M | 1.09M | 1.16M | 1.57M | 1.88M | 1.96M | 1.63M | 1.91M | 1.85M | 1.54M | 1.71M | 1.87M | 1.3M | 46K | 519K | 498K | 2.02M | 980.5K | 980.5K | 267K | 267K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.2M | 3.2M | 2.35M | 2.35M | 1.77M | 2.11M | 3.03M | 2.99M | 3.29M | 2.9M | 3.48M | 2.99M | 3.38M | 3.32M | 3.59M | 3.26M | 1.65M | 880K | 951K | 2.11M | 1.1M | 1.1M | 311K | 311K |
Interest Expense | n/a | n/a | 8.5K | 8.5K | 30K | 41K | n/a | 2.41M | -1.66M | 12K | 276K | 310K | n/a | 10K | 35K | 23K | 1.16M | 8K | n/a | 13K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.2M | 3.2M | 2.35M | 2.35M | 1.77M | 2.11M | 3.03M | 2.99M | 3.29M | 2.9M | 3.48M | 2.99M | 3.38M | 3.32M | 3.59M | 3.26M | 1.65M | 880K | 951K | 2.11M | 1.12M | 1.12M | 325K | 325K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.28M | 1.28M | 1.27M | 1.27M | 1.08M | 990.45K | 902.75K | 770.25K | 768.95K | 681.15K | 681.15K | 589.25K | 589.1K | 579.65K | 579.75K | 565.65K | 547.2K | 538.4K | 547.2K | 279.1K | 279.15K | 279.15K | 272.7K | 272.7K |
Shares Outstanding (Diluted) | 1.28M | 1.28M | 1.27M | 1.27M | 1.08M | 990.45K | 902.75K | 770.25K | 768.95K | 681.15K | 681.15K | 589.25K | 589.1K | 579.65K | 579.75K | 565.65K | 547.2K | 538.4K | 547.2K | 279.15K | 279.2K | 279.2K | 272.7K | 272.7K |
EPS (Basic) | -2.60 | -2.60 | -1.85 | -1.85 | -1.66 | -2.20 | -0.95 | -7 | -3.80 | 1.15 | -7.60 | -5 | -5 | -4.60 | -6 | -4.80 | -0.18 | -1.65 | -1.70 | -3.80 | -4 | -4 | -1.14 | -1.14 |
EPS (Diluted) | -2.60 | -2.60 | -1.85 | -1.85 | -1.66 | -2.20 | -0.95 | -7 | -3.80 | 1.15 | -7.60 | -5 | -5 | -4.60 | -6 | -4.80 | -0.18 | -1.65 | -1.70 | -3.80 | -4 | -4 | -1.14 | -1.14 |
EBITDA | -3.19M | -3.19M | -2.34M | -2.34M | -1.77M | -2.1M | -851.5K | -2.99M | -5.14M | 2.99M | -5.51M | -2.61M | -3.2M | -2.98M | -3.43M | -2.69M | -1.65M | -888K | -939.25K | -2.11M | -1.12M | 16K | 14K | 14K |
EBIT | -3.2M | -3.2M | -2.35M | -2.35M | -1.77M | -2.11M | -857K | -2.99M | -5.15M | 2.99M | -5.53M | -2.61M | -3.2M | -2.98M | -3.45M | -2.69M | -1.65M | -888K | -940K | -2.11M | -1.12M | -1.12M | -325K | -325K |
Depreciation & Amortization | 4K | 4K | 4K | 4K | 5.5K | 5.25K | 5.5K | 5.25K | 5.25K | n/a | 23.5K | 3K | n/a | 750 | 20.5K | 750 | 750 | n/a | 750 | 750 | 750 | 1.12M | 325K | 325K |
Add to Watchlist
Select watchlists to add or remove NRSN